Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV-COVID-19 Vaccine for COVID-19 Prevention
NCT04386252Phase 2Withdrawn
- Sponsor
- AIVITA Biomedical, Inc.
- Start
- Jan 2023
- Primary completion
- Jun 2023
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
01
Overview
A Phase 2 trial of COVID-19 S-Vax loaded autologous dendritic cells in coronavirus disease 2019 (COVID-19), sponsored by AIVITA Biomedical, Inc.. Planned start Jan 2023; status: withdrawn.
02
Drugs
COVID-19 S-Vax loaded autologous dendritic cells
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04386252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04386252.